首页> 外文会议>2015 1st Workshop on Nanotechnology in Instrumentation and Measurement >Preliminary assessment of chitosan nanoparticles for growth factor delivery
【24h】

Preliminary assessment of chitosan nanoparticles for growth factor delivery

机译:壳聚糖纳米颗粒用于生长因子传递的初步评估

获取原文
获取原文并翻译 | 示例

摘要

The aim of this study was to investigate the synthesis of chitosan nanoparticles for growth factor delivery in bone tissue engineering. Chitosan nanoparticles were synthesized via a modified precipitation process and their morphology and dimensions characterized by means of scanning electron microscopy (SEM) and dynamic light scattering (DLS), respectively. In particular, both chitosan molecular weight and concentration were varied during the synthesis to assess the effect of those variables on the particle size and morphology. The stability of the nanoparticles in aqueous media was also assessed, by measuring the average increase of the particle size with time. A specific particle formulation was then selected and loaded with a model molecule, i.e. an oligopeptide derived from the bone morphogenetic protein BMP2. The effect of the nanoparticles on the viability of osteoblast-like MG63 cells was finally assessed in a cytotoxicity assay. The encouraging results obtained in this study, although preliminary, suggested the possible use of chitosan nanoparticles for bone tissue engineering.
机译:这项研究的目的是研究用于骨组织工程中生长因子递送的壳聚糖纳米颗粒的合成。壳聚糖纳米粒子是通过改进的沉淀工艺合成的,其形态和尺寸分别通过扫描电子显微镜(SEM)和动态光散射(DLS)表征。特别是,在合成过程中,壳聚糖的分子量和浓度均发生变化,以评估这些变量对粒度和形态的影响。还通过测量粒度随时间的平均增加来评估纳米颗粒在水性介质中的稳定性。然后选择特定的颗粒制剂并装载模型分子,即衍生自骨形态发生蛋白BMP2的寡肽。最终在细胞毒性试验中评估了纳米颗粒对成骨细胞样MG63细胞活力的影响。尽管是初步研究,但这项研究中获得的令人鼓舞的结果表明,壳聚糖纳米颗粒可用于骨组织工程。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号